Date(s) - 31 Jul 2017 until 1 Aug 2017
7:00 AM - 5:00 PM
The Westin Philadelphia
MedCity CONVERGE is a two-day executive summit that gathers innovative thought leaders from across all healthcare sectors to provide actionable insight on where medical innovation is heading.
AZBio Members benefit with a special rate of $395 with discount code: ARIZONA
(Note: Your company MUST be an AZBio Member to use this discount. Check the AZBio member Directory to confirm your eligibility.)
Dates: July 31, 2-017 – August 1, 2017
Location: The Westin Philadelphia – 99 South 17th Street at Liberty Place
This year, MedCity CONVERGE focuses on one of healthcare’s greatest challenges: cancer.
On July 31-August 1, 2017 in Philadelphia, technology disruptors, along with payers, providers, life science companies, and venture capitalists, will all gather to discuss how AI, Big Data and Precision Medicine are changing the game in cancer.
At CONVERGE, you’ll hear thought-provoking discussions from top healthcare stakeholders across the continuum of care and get actionable insight into how they’re innovating right now.
You’ll also meet the hottest startups and share best practices from some of the country’s most innovative healthcare organizations managing the disease.
We invite you to attend.
Why Attend MedCity CONVERGE?
- CONVERGE reinforces the shift away from silos by gathering healthcare influencers under one roof, underscoring the value of collaboration.
- The conference highlights innovation at every level—from therapeutic and technological innovation to transformations of care delivery and care coordination.
- Meaningful networking opportunities abound, with executives driving the innovation from diverse entities: leading hospital systems, medical device firms, biotech, pharma, emerging technology startups and health IT, as well as the investment community and policymakers.
2016 Audience Breakdown
Last year’s Summit gathered 300 executive-level attendees. CONVERGE annually gathers more than 500 industry leaders.